SMARCA5 restricts chromatin accessibility to promote male meiosis and fertility in mammals
Proceedings of the National Academy of Sciences · 05.08.2025 · 122 (31)
DOI: 10.1073/pnas.2422356122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 31.07.2025. Verfasst von Shubhangini Kataruka und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, Yale School of Medicine, New Haven, CT 06510. Hauptthemen laut MEDLINE: Meiosis, Chromatin, Fertility, Chromosomal Proteins, Non-Histone. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: HHS | NIH | National Cancer Institute (NCI), NICHD NIH HHS, HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
Abstract (Originalsprache)
Establishment of correct chromatin configuration in male meiosis is essential for sperm formation and male fertility. However, how chromatin remodeling contributes to meiotic progression in male germ cells is not well understood. Here, we find that the ISWI family ATP-dependent chromatin remodeling factor SMARCA5 (SNF2H) plays a critical role in regulating meiotic prophase progression during spermatogenesis in mice. Male mice with germ cell-specific depletion of SMARCA5 are infertile and unable to form sperm. Conditional knockout of Smarca5 results in meiotic progression failure, with abnormal spermatocytes appearing at the pachytene stage of meiosis I and subsequent accumulation of defects in chromosome synapsis, DNA repair, and transposon control, along with elevated rates of apoptosis. SMARCA5 interacts with known cofactors BAZ1A/ACF and BAZ2A/TIP5, as well as numerous DNA repair and recombination factors, in the testis. Single cell RNA sequencing confirmed failure to achieve a normal transcriptional state in premeiotic spermatogonia and during meiotic prophase, with reduced levels of meiotic gene transcripts and increasingly aberrant transcriptional states at later stages of spermatogenic development. Transcriptional misregulation in meiotic prophase was preceded by a widespread increase in chromatin accessibility in spermatogonia at promoters and repeat elements. Our findings suggest that SMARCA5 restricts chromatin accessibility in male germ cells to guide appropriate chromatin remodeling during meiotic recombination, contrasting with its role promoting chromatin accessibility during female meiosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Genetics, Yale School of Medicine, New Haven, CT 06510.
- Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, New Haven CT 06510.
- Yale Cancer Center, Yale School of Medicine, New Haven, CT 06510.
ORCID-Profile: Shubhangini Kataruka, Aushaq B Malla, Benjamin William Walters, Bluma J Lesch
Förderung
- HHS | NIH | National Cancer Institute (NCI)
- NICHD NIH HHS
- HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- NIH HHS
- Pew Charitable Trusts (PEW)
- NCI NIH HHS
- Surdna Foundation (SF)
Zitieren
APA
Kataruka, S., Malla, A. B., Rainsford, S. R., Walters, B. W., Heuer, R. A., Marshall, K. L., & Lesch, B. J. (2025). SMARCA5 restricts chromatin accessibility to promote male meiosis and fertility in mammals. Proceedings of the National Academy of Sciences, 122(31). https://doi.org/10.1073/pnas.2422356122
Vancouver
Kataruka S, Malla AB, Rainsford SR, Walters BW, Heuer RA, Marshall KL, et al. SMARCA5 restricts chromatin accessibility to promote male meiosis and fertility in mammals. Proceedings of the National Academy of Sciences. 2025;122(31). doi:10.1073/pnas.2422356122
BibTeX
@article{Kataruka2025,
author = {Kataruka, Shubhangini and Malla, Aushaq B and Rainsford, Shannon R and Walters, Benjamin William and Heuer, Rachel A and Marshall, Kira L and Lesch, Bluma J},
title = {SMARCA5 restricts chromatin accessibility to promote male meiosis and fertility in mammals},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
volume = {122},
number = {31},
doi = {10.1073/pnas.2422356122}
}
EUVIMED